Le Lézard
Classified in: Science and technology
Subjects: Conference, Webcast, Advisory

Aptiv to Present at Wolfe Research Global Auto and Auto Tech Conference


Aptiv PLC (NYSE: APTV), a global technology company focused on making mobility safer, greener and more connected, will present at the Wolfe Research Global Auto and Auto Tech Conference, February 15 at 10:20 a.m. Eastern Time.

A simultaneous webcast will be available on the Aptiv Investor Relations website at ir.aptiv.com.

About Aptiv

Aptiv is a global technology company that develops safer, greener and more connected solutions enabling a more sustainable future of mobility. Visit aptiv.com.


These press releases may also interest you

at 12:10
Xsolla, a global video game commerce company, announces a new partnership with Curve Games, the award-winning London-based publisher of several notable independent games. The alliance will leverage Xsolla's Web Shop to support Curve Games in...

at 12:05
Mintegral, a programmatic subsidiary of leading advertising technology company Mobvista (1860.HK), has launched an advanced model for precise user acquisition (UA). The new model, Target CPE (Cost Per Engagement), helps advertisers achieve lifetime...

at 12:00
Ekinops (Euronext Paris: EKI) (ISIN: FR0011466069), a leading supplier of optical transport and enterprise connectivity solutions for telecom operators and enterprises, today announced that Orange Business has chosen Ekinops technology to launch its...

at 12:00
Trianz, a global digital transformation technology solutions and services firm, is thrilled to announce the appointment of Priyanshu Singh as its new VP & Chief of Staff. This strategic hire comes at a pivotal moment as Trianz continues to experience...

at 12:00
Marelli, a leading global mobility technology supplier, announced that Kelei Shen is assuming the role of Executive Vice President and President China effective July 1, 2024. He will lead Marelli's ambitious growth plans for China....

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...



News published on and distributed by: